Skip to main content
Erschienen in: Diabetologia 7/2004

01.07.2004 | Article

Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects

verfasst von: S. Kipfer-Coudreau, D. Eberlé, M. Sahbatou, A. Bonhomme, B. Guy-Grand, P. Froguel, P. Galan, A. Basdevant, K. Clément

Erschienen in: Diabetologia | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The development of insulin resistance may contribute to the occurrence and progression of the metabolic syndrome associated with obesity. Components contributing to the insulin pathway and its regulation are good candidates for the molecular study of metabolic syndrome pathogenesis. Protein tyrosine phosphatase 1B (PTP 1B) is an important negative regulator of insulin. We investigated whether PTP 1B SNPs are associated with obesity and obesity-related traits as well as global metabolic syndrome in morbidly obese subjects.

Methods

Untranslated and coding regions of the PTP 1B gene were screened in groups of non-diabetic and diabetic obese subjects and in non-obese subjects. Unrelated morbidly obese (n=711) and non-obese (n=427) French Caucasian subjects were genotyped for a case-control study.

Results

Six SNPs were identified: two rare variants were located in 5′UTR (−109 C>T and −69 C>T), two in the intronic regions (IVS3+38 G>T and IVS5+3666delT) and two have been described previously (P303P in exon 8 and P387L in exon 9). A case-control study showed an association between the frequent IVS5+3666delT SNP and obesity (p=0.02). In the obese group, associations between PTP 1B SNPs and features of dyslipidaemia were found. P303P was associated with lower apolipoprotein A1 levels (p=0.05) whereas P387L was associated with higher triglyceride (p=0.0003), apolipoprotein B (p=0.09) and lipoprotein a concentrations (p=0.006).

Conclusions/interpretation

Our results support the hypothesis that the PTP 1B gene contributes to the polygenic basis of obesity. PTP 1B SNPs may interact with environmental factors to induce more severe phenotypes, e.g. atherogenic dyslipidaemia, in morbidly obese subjects.
Literatur
1.
Zurück zum Zitat Reaven G (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106:286–288CrossRefPubMed Reaven G (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106:286–288CrossRefPubMed
2.
Zurück zum Zitat Haffner S, Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation 108:1541–1545CrossRefPubMed Haffner S, Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation 108:1541–1545CrossRefPubMed
3.
4.
Zurück zum Zitat Meigs JB, D’Agostino RBS, Wilson PW et al. (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 6:1594–1600CrossRef Meigs JB, D’Agostino RBS, Wilson PW et al. (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 6:1594–1600CrossRef
5.
Zurück zum Zitat Hanley AJ, Karter AJ, Festa A et al. (2002) Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51:2642–2647CrossRefPubMed Hanley AJ, Karter AJ, Festa A et al. (2002) Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51:2642–2647CrossRefPubMed
7.
Zurück zum Zitat White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269:1–4PubMed White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269:1–4PubMed
8.
Zurück zum Zitat Seely BL, Staubs PA, Reichart DR et al. (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379–1385CrossRefPubMed Seely BL, Staubs PA, Reichart DR et al. (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379–1385CrossRefPubMed
9.
Zurück zum Zitat Worm D, Vinten J, Beck-Nielsen H (1999) The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling. Diabetologia 42:1146–1149CrossRefPubMed Worm D, Vinten J, Beck-Nielsen H (1999) The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling. Diabetologia 42:1146–1149CrossRefPubMed
10.
Zurück zum Zitat Ukkola O, Santaniemi M (2002) Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities. J Intern Med 251:467–475CrossRefPubMed Ukkola O, Santaniemi M (2002) Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities. J Intern Med 251:467–475CrossRefPubMed
11.
Zurück zum Zitat Elchebly M, Payette P, Michaliszyn E et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548CrossRefPubMed Elchebly M, Payette P, Michaliszyn E et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548CrossRefPubMed
12.
Zurück zum Zitat Klaman LD, Boss O, Peroni OD et al. (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–5489CrossRefPubMedPubMedCentral Klaman LD, Boss O, Peroni OD et al. (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–5489CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rondinone CM, Trevillyan JM, Clampit J et al. (2002) Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 51:2405–2411CrossRefPubMed Rondinone CM, Trevillyan JM, Clampit J et al. (2002) Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 51:2405–2411CrossRefPubMed
14.
Zurück zum Zitat Osborne TF (2000) Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 275:32379–32382CrossRefPubMed Osborne TF (2000) Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 275:32379–32382CrossRefPubMed
15.
Zurück zum Zitat Shimizu S, Ugi S, Maegawa H et al. (2003) Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 44:43095–43101CrossRef Shimizu S, Ugi S, Maegawa H et al. (2003) Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 44:43095–43101CrossRef
16.
Zurück zum Zitat Brown-Shimer S, Johnson KA, Lawrence JB et al. (1990) Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci USA 87:5148–5152CrossRefPubMedPubMedCentral Brown-Shimer S, Johnson KA, Lawrence JB et al. (1990) Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci USA 87:5148–5152CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lembertas AV, Perusse L, Chagnon YC et al. (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240–1247CrossRefPubMedPubMedCentral Lembertas AV, Perusse L, Chagnon YC et al. (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240–1247CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Echwald SM, Bach H, Vestergaard H et al. (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1–6CrossRefPubMed Echwald SM, Bach H, Vestergaard H et al. (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1–6CrossRefPubMed
19.
Zurück zum Zitat Mok A, Cao H, Zinman B et al. (2002) A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. J Clin Endocrinol Metab 87:724–727CrossRefPubMed Mok A, Cao H, Zinman B et al. (2002) A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. J Clin Endocrinol Metab 87:724–727CrossRefPubMed
20.
Zurück zum Zitat Di Paola R, Frittitta L, Miscio G et al. (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806–812CrossRef Di Paola R, Frittitta L, Miscio G et al. (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806–812CrossRef
21.
Zurück zum Zitat Clement K, Vaisse C, Manning BS et al. (1995) Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352–354CrossRefPubMed Clement K, Vaisse C, Manning BS et al. (1995) Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352–354CrossRefPubMed
22.
Zurück zum Zitat Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077CrossRefPubMed Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077CrossRefPubMed
23.
Zurück zum Zitat Hercberg S, Preziosi P, Briancon S et al. (1998) A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 19:336–351CrossRefPubMed Hercberg S, Preziosi P, Briancon S et al. (1998) A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clin Trials 19:336–351CrossRefPubMed
24.
Zurück zum Zitat Mattews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRef Mattews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRef
25.
Zurück zum Zitat Dubern B, Clement K, Pelloux V et al. (2001) Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 139:204–209CrossRefPubMed Dubern B, Clement K, Pelloux V et al. (2001) Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 139:204–209CrossRefPubMed
26.
27.
Zurück zum Zitat Slatkins M (1994) Linkage disequilibrium in growing and stable populations. Genetics 137:331–336 Slatkins M (1994) Linkage disequilibrium in growing and stable populations. Genetics 137:331–336
28.
29.
Zurück zum Zitat Altshuler D, Hirschhorn JN, Klannemark M et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80CrossRefPubMed Altshuler D, Hirschhorn JN, Klannemark M et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80CrossRefPubMed
30.
Zurück zum Zitat Vakkilainen J, Steiner G, Ansquer JC et al. (2003) Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107:1733–1737CrossRefPubMed Vakkilainen J, Steiner G, Ansquer JC et al. (2003) Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107:1733–1737CrossRefPubMed
32.
Zurück zum Zitat Flint AJ, Gebbink MF, Franza BR Jr, Hill DE, Tonks NK (1993) Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J 12:1937–1946PubMedPubMedCentral Flint AJ, Gebbink MF, Franza BR Jr, Hill DE, Tonks NK (1993) Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J 12:1937–1946PubMedPubMedCentral
33.
Zurück zum Zitat Schievella AR, Paige LA, Johnson KA, Hill DE, Erikson RL (1993) Protein tyrosine phosphatase 1B undergoes mitosis-specific phosphorylation on serine. Cell Growth Differ 4:239–246PubMed Schievella AR, Paige LA, Johnson KA, Hill DE, Erikson RL (1993) Protein tyrosine phosphatase 1B undergoes mitosis-specific phosphorylation on serine. Cell Growth Differ 4:239–246PubMed
34.
Zurück zum Zitat Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411–414CrossRefPubMed Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411–414CrossRefPubMed
35.
Zurück zum Zitat Forsell PA, Boie Y, Montalibet J, Collins S, Kennedy BP (2000) Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. Gene 260:145–153CrossRefPubMed Forsell PA, Boie Y, Montalibet J, Collins S, Kennedy BP (2000) Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. Gene 260:145–153CrossRefPubMed
Metadaten
Titel
Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects
verfasst von
S. Kipfer-Coudreau
D. Eberlé
M. Sahbatou
A. Bonhomme
B. Guy-Grand
P. Froguel
P. Galan
A. Basdevant
K. Clément
Publikationsdatum
01.07.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 7/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1432-5

Weitere Artikel der Ausgabe 7/2004

Diabetologia 7/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.